Essential CNS Drug Development || Phase II development and the path to personalized medicine in CNS disease
Kalali, Amir, Kwentus, Joseph, Preskorn, Sheldon, Stahl, Stephen M.Volume:
10.1017/CB
Year:
2012
Language:
english
DOI:
10.1017/CBO9780511977640.006
File:
PDF, 244 KB
english, 2012